| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |